Blood Dialyzer Market Product Type (Single Use Dialyzer, Reusable Dialyzer), By Membrane Type (Synthetic Membrane, Non-synthetic Membrane), By End User Segment (Hospitals and Clinics, Dialysis Centers, Ambulatory Surgical Centers, Home Care Settings) - Growth, Future Prospects & Competitive Analysis, 2019 – 2027

Blood Dialyzer Market to Exhibit Dynamic Growth During the Forecast Period

The global blood dialyzer market is increasing proficiently and is expected to grow at a CAGR of 7.0%. Worldwide, the increasing prevalence of chronic or acute kidney failure and other kidney-related disorders, along with hemodialysis (a procedure for the removal of waste from the blood), will drive the overall growth of the market. Growing awareness about new synthetic membrane technology to overcome the limitations of traditional procedures, along with the launch of advanced products with compatible solutions, will increase the overall demand in the near future. The increasing popularity of renal replacement therapy, the increasing burden of kidney diseases and urinary disorders in developing nations, rising geriatric populations, and a rise in the number of U.S. FDA approvals for blood dialyzers will spur revenue growth during the forecast period.

Market Synopsis 

Synthetic products are expected to register higher growth by the end of 2027.

Advancements in synthetic dialyzers, along with developments in the fields of membrane materials and biocompatibility, will drive market growth. Non-synthetic membrane types are mainly derived from natural products such as cotton and are less biocompatible compared to synthetic products. For example, PSF (polysulfone and a family of polysulfone blends), PES (polyethersulfone), CTA (cellulose triacetate), PMMA (polymethylmethacrylate), PEPA (PES plus polyacrylate), EVAL (ethylene vinyl alcohol copolymers), and PAN (polyacrylonitrile). High-flux dialyzers will generate maximum revenue share on a global scale. Membranes in the new super-high-flux dialyzers are primarily PES and PSF.

Single-use dialyzers to witness a significant CAGR.

Preference for single-use dialyzers generated the largest market share in 2018, whereas reusable products may contain the risk of infection and contamination. Moreover, a large patient pool with kidney failure and renal diseases, mainly end-stage renal disorders, on a global scale will drive growth globally. Advancement in synthetic membrane technology, along with the usage of high-flux synthetic membranes in dialysis centers and hospitals, offers a huge advantage in the global blood dialyzer industry. For e.g., In June 2018, FDA approved Ellipsys Vascular Access System for non-surgical dialysis fistula creation, and EverlinQ EndoAVF received FDA de novo marketing approval.

Increased research and development with strong product pipelines in the developed regions

Major players in the blood dialyzer market are Fresenius Medical Care AG & Co. KGaA, Baxter International, Inc., B. Braun Melsungen AG, Diaverum Deutschland GmbH, NIPRO Medical Corporation, Medica Group, Dialifegroup, Asahi Kasei, NIKKISO CO., LTD., Allmed Medical Care Holdings Limited, Farmasol, Serumwerk Bernburg AG, and others. Major enterprises are developing new synthetic technology and advanced biocompatible materials with collective biological solutions. New product launches, partnerships, acquisitions, technology expansion in developing nations, and enhanced R&D on blood dialyzers will drive the market's growth during the forecast period.

Historical and Forecast Period

This study report represents an analysis of each segment from 2017 to 2027, considering 2018 to be the base year. The compound annual growth rate (CAGR) for each of the respective segments is estimated for the forecast period from 2019 to 2027.

Report Scope by Segments

Market Segmentation

The current report also encompasses qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints, and opportunities that give a better understanding of the overall blood dialyzer market. Additionally, the global report also comprises a graphical representation of the competitive landscape based on their market initiatives and strategies, product portfolios, and business strengths.

Key questions are answered in this report.

  • What are the current market trends and dynamics in the blood dialyzer market, and what are the valuable opportunities for emerging players?
  • Which segment accounts for the fastest CAGR during the forecast period and why?
  • Which product type segment holds a larger market share and why?
  • Are low- and middle-income economies investing in the blood dialyzer market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and the Middle East and Africa?

 Frequently Asked Questions:

The market for Blood Dialyzer Market is expected to reach XX Bn in 2027.

The Blood Dialyzer Market is expected to see significant CAGR growth over the coming years, at 7.0%.

The report is forecasted to 2019-2027.

The base year of this report is 2018.

Fresenius Medical Care AG & Co. KGaA,Baxter International, Inc.,B. Braun Melsungen AG,Diaverum Deutschland GmbH, NIPRO Medical Corporation are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Aug 2019
Category:  Medical Devices
Report ID:   59859
Report Format:   PDF
Pages:   120
Rating:    4.2 (69)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support